People

Jacob Falck Hansen

Jacob Falck Hansen is listed by the Lundbeck Foundation as Partner. Former Novo Nordisk corporate-strategy head with fifteen years across pharma strategy and leadership advice. University of Copenhagen biochemistry MSc/PhD and research-publication background. Own biography identifies Vesper Bio CEO and several board/observer affiliations; no personal investment is inferred. Jacob Falck Hansen is currently listed by Vesper Bio as CEO. Previously led Novo Nordisk corporate strategy and holds Copenhagen biochemistry MSc/PhD; appointed Vesper CEO July2025.